Geriatric factors to predict toxicity and dose-intensity reduction in FFCD 2001-02 phase III study comparing a first-line chemotherapy of LV5FU2 or FOLFIRI in treatment of metastatic colorectal cancer (mCRC) in elderly patients.

Thomas Aparicio,Jean-Louis Jouve,Laurent Teillet,Dany Gargot,V. Le Brun Ly,J Cretin,Christophe Locher,Olivier Bouche,Gilles Breysacher,J. Charneau,J.-F. Seitz,Mohamed Gasmi,F Ricard,Fabien Subtil,Emmanuel Mitry,Federation Francophone de Cancerologie Digestive

Geriatric factors to predict toxicity and dose-intensity reduction in FFCD 2001-02 phase III study comparing a first-line chemotherapy of LV5FU2 or FOLFIRI in treatment of metastatic colorectal cancer (mCRC) in elderly patients.

2011

Thomas Aparicio
Jean-Louis Jouve
Laurent Teillet
Dany Gargot
V. Le Brun Ly
J Cretin
Christophe Locher
Olivier Bouche
Gilles Breysacher
J. Charneau
J.-F. Seitz
Mohamed Gasmi
F Ricard
Fabien Subtil
Emmanuel Mitry
Federation Francophone de Cancerologie Digestive

9111 Background: Elderly patients form a heterogeneous population. The evaluation of geriatric factors could help the selection of eligible patients for an intensified chemotherapy. Methods: Elderl...

Keywords:

FOLFIRI
Colorectal cancer
Cancer research
Physical therapy
Toxicity
Chemotherapy
Oncology
Medicine
Internal medicine
dose intensity
first line chemotherapy
heterogeneous population

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations